If you want to receive notifications of upcoming IPOs, you need to simply sign up or sign in with social networks.
IPO Filter
Monitor
IPO today
Upcoming IPO
Attovia Therapeutics (ATTO)
Braveheart Bio (BRVE)
Vogenx (VOGX)
Web3Labs Global Inc. (MDAT)
BlossomHill Therapeutics (BLSM)
Latigo Biotherapeutics (LTGO)
Riku Dining Group (RIKU)
BW Industrial Holdings (BWGC)
MetaOptics (Uplisting) (MOT)
Londian Wason New Energy Tech (FOIL)
Priced IPO
Apnimed (APMD)
DSC Holdings Ltd. (DSC)
Duke Robotics Corp. (Uplisting/Units) (DUKR)
Exyn Technologies (Unit IPO) (EXYN)
VIDA Global (Brief) (VIDA)
Pershing Square USA/Pershing Square Inc. (Closed-End Fund) (PSUS/PS)
Liberty Defense Holdings, Ltd. (Uplisting) (DETX)
Guardian Metal Resources PLC (Uplisting) (GMTL)
Janus Living (JAN)
MDA Space Ltd. (Uplisting) (MDA)
FreeCast (Direct Listing) (CAST)
Braiin Ltd. (Direct Listing) (BRAI)
Atlas Critical Minerals (Uplisting) (ATCX)
Functional Brands (Direct Listing) (MEHA)
Leifras Co., Ltd. (LFS)
CCH Holdings Ltd. (CCHH)
Agroz Inc. (AGRZ)
Platinum Analytics Cayman Ltd. (PLTS)
ChowChow Cloud International Holdings (CHOW)
Zenta Group (ZGM)
More companies
BlossomHill Therapeutics (BLSM)
Buy BitcoinIPO Profile
About company
(Note: EGFR stands for epidermal growth factor receptor.) Lung cancer is the most common cause of death worldwide. Non-small cell lung cancer (NSCLC) accounts for about 85 percent of all lung cancer cases. According to GlobalData, about 316,000 patients were diagnosed with EGFR-mutant NSCLC across key global markets of the United States, Europe, Japan and China in 2025. Activating mutations in the EGFR gene represent the most common targetable oncogenic driver in NSCLC and define a clinically and molecularly distinct patient population.
Contacts
Address: 10255 Science Center Drive Suite 200 San Diego, California 92121
Telephone: (858) 732-3880
Web page: https://www.bhtherapeutics.com/
IPO information
Shares & Volumes
| Shares Initial (MM) | 7.8 |
|---|---|
| Shares Revised (MM) | - |
| Expected offer amount (MM) | $125 |
| Realized offer amount(MM) | - |
Financial Data (last reporting year)
| Market Cap (MM) | $465.28 |
|---|---|
| Revenues (MM) | $0.0 |
| Net Income (Loss) (MM) | $-71.09 |
Voting
What do you think will happen with the BLSM share price after the next 3-6 months? 🔥 (+ 10% or more, flat (+ -10%), -10% or less)
| IPOs led by the firm | .Pro |
|---|---|
| Profitability of conducted IPOs ? | .Pro |
| 1st day change ? | .Pro |
| Change for the first 3 months ? | .Pro |
| Underwriters |
|---|
| J.P.Morgan/Leerink Partners/Guggenheim Securities/LifeSci Capital/H.C. Wainwright |
| CO-Managers |
Tweets about $BLSM
Google Trends Stats